Universal Health Services
UHS
174.62
-2.46
-1.39%
Universal Health Services
US · UHS
#1440 by market cap
Listed 1970
174.62
-2.46
-1.39%
Live - 5344 symbols - heartbeat 552s ago
· 2026-10-08 07:58
Pre-market
174.62
0.00%
After-hours
174.62
0.00%
- Market cap
- 10.29B
- P/E (TTM)i
- 7.13
- P/Bi
- 1.37
- EPSi
- 23.10
- Div yieldi
- 0.46%
- 52W posi
- 33%
Reader sentiment
Are you bullish or bearish on UHS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 14 analysts
Buy
Avg price target
195.62 +12.0%
Price target rangecurrent 174.62
Low166.00
Avg195.62
High290.00
Buy 36%
Hold 57%
Sell 7%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Raymond James | -- | HOLD | -- |
| 2026-09-18 | Leerink Partners | -- | BUY | 205.00 |
| 2026-09-17 | Leerink Partners | -- | BUY | -- |
| 2026-09-03 | J.P. Morgan | -- | HOLD | 200.00 |
| 2026-08-31 | UBS | -- | BUY | 290.00 |
| 2026-08-25 | UBS | -- | BUY | 290.00 |
| 2026-08-19 | RBC Capital | -- | HOLD | 183.00 |
| 2026-08-10 | BofA Securities | -- | SELL | 170.00 |
| 2026-08-02 | RBC Capital | -- | HOLD | 183.00 |
| 2026-07-30 | Goldman Sachs | -- | HOLD | 190.00 |
| 2026-07-29 | TD Cowen | -- | BUY | 197.00 |
| 2026-07-29 | UBS | -- | BUY | 290.00 |
| 2026-07-29 | Morgan Stanley | -- | HOLD | 191.00 |
| 2026-07-28 | TD Cowen | -- | BUY | 197.00 |
| 2026-07-28 | Cantor Fitzgerald | -- | HOLD | 194.00 |
| 2026-07-28 | BofA Securities | -- | SELL | -- |
| 2026-07-28 | Guggenheim | -- | BUY | 189.00 |
| 2026-07-28 | Barclays | -- | HOLD | 168.00 |
| 2026-07-27 | Cantor Fitzgerald | -- | HOLD | 194.00 |
| 2026-07-27 | Goldman Sachs | -- | HOLD | 242.00 |
| 2026-07-20 | Guggenheim | -- | BUY | 195.00 |
| 2026-07-13 | Wells Fargo | -- | HOLD | 166.00 |
| 2026-07-13 | Mizuho Securities | -- | BUY | 200.00 |
| 2026-07-09 | RBC Capital | -- | HOLD | 190.00 |
| 2026-07-08 | Barclays | -- | HOLD | 179.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
3
■ Upgrades■ Downgrades
- 0 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: Barclays moved from Buy to Hold on 2026-07-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-08 | Barclays | BUY → HOLD | 179.00 |
| 2026-04-29 | Raymond James | BUY → HOLD | -- |
| 2026-01-07 | Wells Fargo | BUY → HOLD | 235.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-27 | After close | ±9.10% | +4.34% (in line) |
| 2026/Q1 | 2026-04-27 | After close | ±7.79% | -9.45% (beat) |
| 2025/Q4 | 2026-02-25 | After close | ±7.83% | -11.44% (beat) |
| 2025/Q3 | 2025-10-27 | After close | ±6.51% | +2.47% (in line) |
| 2025/Q2 | 2025-07-28 | After close | ±10.03% | +5.08% (in line) |
| 2025/Q1 | 2025-04-28 | After close | ±10.06% | -0.60% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±9.77% | +3.30% (in line) |
| 2024/Q3 | 2024-10-24 | After close | ±11.65% | -9.75% (in line) |
| 2024/Q2 | 2024-07-24 | After close | ±7.82% | +10.23% (beat) |
| 2024/Q1 | 2024-04-24 | After close | ±7.30% | -0.48% (in line) |
| 2023/Q4 | 2024-02-27 | After close | ±7.29% | -2.45% (in line) |
| 2023/Q3 | 2023-10-25 | After close | ±12.93% | +1.65% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:58:34 · For reference only, not investment advice and not tailored to your situation.